Sign up to save your podcasts
Or
Share Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6262 ratings
Dr Hope S Rugo from City of Hope Comprehensive Cancer Center in Duarte, California, discusses the efficacy and safety of approved and investigational antibody-drug conjugates for endocrine-resistant HR-positive and triple-negative metastatic breast cancer.
CME information and select publications here.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
323 Listeners
JAMA Clinical Reviews
499 Listeners
Lung Cancer Update
30 Listeners
Hematologic Oncology Update
76 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
121 Listeners
ASCO Daily News
57 Listeners
Mayo Clinic Talks
293 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
The ONS Podcast
205 Listeners
The Clinical Problem Solvers
514 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Two Onc Docs
193 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners